CalciMedica, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies that target calcium release-activated calcium (CRAC) channels for serious inflammatory, immunologic, and cardiopulmonary diseases. The company’s lead candidate, Auxora, is an intravenous small-molecule CRAC channel inhibitor being evaluated in multiple settings, including acute pancreatitis, acute kidney injury, and other severe inflammatory conditions. CalciMedica also develops an oral CRAC channel inhibitor program aimed at chronic inflammatory and immunologic diseases. Its current work centers on drug discovery and clinical development for conditions where inflammation and direct cellular injury drive high unmet medical need. Based in La Jolla, California, CalciMedica plays a specialized role in the biotechnology market by advancing a differentiated calcium-channel inhibition platform for acute and chronic disease areas.
Website505 Coast Boulevard South
La Jolla, CA, 92037
United States
Detailed price information for Calcimedica Inc (CALC-Q) from The Globe and Mail including charting and trades.
Detailed price information for Calcimedica Inc (CALC-Q) from The Globe and Mail including charting and trades.
Detailed price information for Calcimedica Inc (CALC-Q) from The Globe and Mail including charting and trades.
Investors talking about CALC also mention
What share of all stock conversation is about CALC?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Attention | 0% 0 | 0% 0 | 0% 0 | 0% +0 |
Of the messages about CALC that take a side, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Bullish | — | 45.45% -34.55 | 75% +4.46 | 80.89% -8.42 | ||
| Bearish | — | 54.55% +34.55 | 25% -4.46 | 19.11% +8.42 |
Of the messages about CALC that carry a topic, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Technical Analysis | — | 100% | 100% | 10.86% | ||
| Announcements | — | 0% | 0% | 57.32% | ||
| Analysts | — | 0% | 0% | 16.67% | ||
| Controversies | — | 0% | 0% | 0.76% | ||
| Earnings | — | 0% | 0% | 0.25% | ||
| Macro | — | 0% | 0% | 14.14% |
Of the messages about CALC, what share comes from each group?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Regulars | 100% | 85.71% | 76.56% | 31.61% | ||
| Newcomers | 0% | 14.29% | 23.44% | 68.39% |